PPA
CERE

Parametric Portfolio Associates’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Parametric Portfolio Associates’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		$808K Sell
23,090
-40,199
-64% -$1.41M ﹤0.01% 2875
2021
Q4 		$2.05M Buy
63,289
+7,650
+14% +$248K ﹤0.01% 2422
2021
Q3 		$1.64M Buy
55,639
+21,446
+63% +$633K ﹤0.01% 2544
2021
Q2 		$876K Buy
+34,193
New +$876K ﹤0.01% 2825